SkinBioTherapeutics (GB:SBTX) has released an update.
SkinBioTherapeutics, a life science company specializing in skin health, has announced a business update and an investor presentation scheduled for 29 July 2024. Interested investors can engage with the company’s management via the Investor Meet Company platform, where they can submit questions before or during the live event. The company, known for its proprietary SkinBiotix® platform targeting various skin healthcare sectors, aims to demonstrate its technology through human studies.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
